These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12362292)

  • 1. Pathogenesis of hepatitis C virus recurrence in the liver allograft.
    McCaughan GW; Zekry A
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S7-S13. PubMed ID: 12362292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of immunosuppression on immunopathogenesis of liver damage in hepatitis C virus-infected recipients following liver transplantation.
    McCaughan GW; Zekry A
    Liver Transpl; 2003 Nov; 9(11):S21-7. PubMed ID: 14586891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ
    Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
    Zekry A; Bishop GA; Bowen DG; Gleeson MM; Guney S; Painter DM; McCaughan GW
    Liver Transpl; 2002 Mar; 8(3):292-301. PubMed ID: 11910576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.
    Pelletier SJ; Raymond DP; Crabtree TD; Berg CL; Iezzoni JC; Hahn YS; Sawyer RG; Pruett TL
    Hepatology; 2000 Aug; 32(2):418-26. PubMed ID: 10915752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Gonzalez-Koch A; Maor-Kendler Y; Batts K; Moreno-Luna L; Poterucha J; Burgart L; Wiesner R; Kremers W; Rosen C; Charlton MR
    Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.
    Schirren CA; Jung MC; Worzfeld T; Mamin M; Baretton G; Gerlach JT; Gruener NH; Zachoval R; Houghton M; Rau HG; Pape GR
    J Infect Dis; 2001 Apr; 183(8):1187-94. PubMed ID: 11262200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Rasmussen DL; Wiesner RH; Charlton MR
    Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence.
    Charlton M
    Liver Transpl; 2003 Nov; 9(11):S58-62. PubMed ID: 14586897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation.
    Pelletier SJ; Raymond DP; Crabtree TD; Iezzoni JC; Sawyer RG; Hahn YS; Pruett TL
    Hepatology; 2000 Aug; 32(2):375-81. PubMed ID: 10915745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver.
    Ballardini G; De Raffele E; Groff P; Bioulac-Sage P; Grassi A; Ghetti S; Susca M; Strazzabosco M; Bellusci R; Iemmolo RM; Grazi G; Zauli D; Cavallari A; Bianchi FB
    Liver Transpl; 2002 Jan; 8(1):10-20. PubMed ID: 11799480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
    Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
    Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
    Gottschlich MJ; Aardema KL; Burd EM; Nakhleh RE; Brown KA; Abouljoud MS; Hirst K; Moonka DK
    Liver Transpl; 2001 May; 7(5):436-41. PubMed ID: 11349265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of recurrent hepatitis C.
    Berenguer M
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S14-8. PubMed ID: 12362293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.
    Lautenschlager I; Nashan B; Schlitt HJ; Hoshino K; Ringe B; Tillmann HL; Manns M; Wonigeit K; Pichlmayr R
    Transplantation; 1994 Dec; 58(12):1339-45. PubMed ID: 7809926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C; di Francesco F; Marino IR; Ramirez CB; Frank A; Iaria M; Galati SA; Farber JL
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.